0000950170-24-092967.txt : 20240807 0000950170-24-092967.hdr.sgml : 20240807 20240807170553 ACCESSION NUMBER: 0000950170-24-092967 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20240802 ITEM INFORMATION: Cost Associated with Exit or Disposal Activities FILED AS OF DATE: 20240807 DATE AS OF CHANGE: 20240807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FIBROGEN INC CENTRAL INDEX KEY: 0000921299 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36740 FILM NUMBER: 241184896 BUSINESS ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-978-1200 MAIL ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 8-K 1 fgen-20240802.htm 8-K 8-K
0000921299false00009212992024-08-022024-08-02

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 02, 2024

 

 

FIBROGEN, INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

001-36740

77-0357827

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

409 Illinois Street

 

San Francisco, California

 

94158

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 415 978-1200

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, $0.01 par value

 

FGEN

 

The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 2.05 Costs Associated with Exit or Disposal Activities.

On August 2, 2024, FibroGen, Inc. (the “Company”) initiated a restructuring plan (the “Plan”) to lower the Company’s operating expenses in light of the negative pamrevlumab clinical trial data announced earlier that week. The Plan includes an expected reduction to the Company’s U.S. workforce of approximately 75% with 127 U.S. employees noticed on August 2, 2024.

The Company would like to extend its tremendous gratitude to these employees, not only for their contributions to the strong workforce and culture at FibroGen, but to their large part in the progress we have made, and continue to make, in science and the biotechnology industry.

The Company estimates that it will incur non-recurring charges in the range of $16-18 million in connection with the Plan, primarily consisting of severance payments, notice pay, accrued vacation, payroll tax and employee benefits contributions. The Company expects that the majority of the restructuring charges will be incurred in the second half of 2024 and that the implementation of the headcount reductions, including cash payments, will be substantially complete by the end of the first quarter of 2025.

Potential position eliminations are subject to legal requirements that vary by jurisdiction, which may extend this process beyond the first quarter of 2025 in certain cases. The charges that the Company expects to incur, and the savings obtained, are subject to a number of assumptions, including legal requirements in various jurisdictions, and actual expenses and savings may differ materially from the estimates disclosed above. The Company may incur additional costs not currently contemplated due to events that may occur as a result of, or that are associated with, the reduction.

Note Regarding Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements as that term is defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements involve substantial risks and uncertainties. All statements other than statements of historical fact contained in this Form 8-K are forward-looking statements including statements relating to the Company’s plans, expectations, forecasts and future events. Such forward-looking statements include, but are not limited to, the potential of, and expectations regarding the Company’s business strategy, statements relating to the anticipated timing and details of the Plan and the expected impacts, charges and costs associated with the Plan that the Company expects to incur. In some cases, you can identify forward-looking statements by terminology such as “believe,” “estimate,” “intend,” “may,” “plan,” “potentially,” “will,” “expect,” “enable,” “likely” or the negative of these terms or other similar expressions. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Actual events, trends or results could differ materially from the plans, intentions and expectations disclosed in these forward-looking statements based on various factors. Information regarding the foregoing and additional risks may be found in the section entitled “Risk Factors” in the Company’s most recent Annual and Quarterly Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission (the “SEC”), and the Company’s future reports to be filed with the SEC. These forward-looking statements are made as of the date of this 8-K, and the Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

FIBROGEN, INC.

 

 

 

 

Date:

August 7, 2024

By:

/s/ Michael Lowenstein

 

 

 

Michael Lowenstein
Chief Legal Officer

 


EX-101.SCH 2 fgen-20240802.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink Cover [Abstract] Amendment Flag City Area Code Document Period End Date Document Type Entity Address, Address Line One Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, State or Province Entity Central Index Key Entity Emerging Growth Company Entity File Number Entity Incorporation, State or Country Code Entity Registrant Name Entity Tax Identification Number Local Phone Number Pre-commencement Issuer Tender Offer Pre-commencement Tender Offer Title of 12(b) Security Security Exchange Name Soliciting Material Trading Symbol Written Communications XML 4 R1.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Document And Entity Information
Aug. 02, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Aug. 02, 2024
Entity Registrant Name FIBROGEN, INC.
Entity Central Index Key 0000921299
Entity Emerging Growth Company false
Entity File Number 001-36740
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 77-0357827
Entity Address, Address Line One 409 Illinois Street
Entity Address, City or Town San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94158
City Area Code 415
Local Phone Number 978-1200
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $0.01 par value
Trading Symbol FGEN
Security Exchange Name NASDAQ
EXCEL 5 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 6 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 7 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 9 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.2.u1 html 1 22 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document And Entity Information Sheet http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation Document And Entity Information Cover 1 false false All Reports Book All Reports fgen-20240802.htm fgen-20240802.xsd http://xbrl.sec.gov/dei/2024 false false JSON 11 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "fgen-20240802.htm": { "nsprefix": "fgen", "nsuri": "http://www.fibrogen.com/20240802", "dts": { "inline": { "local": [ "fgen-20240802.htm" ] }, "schema": { "local": [ "fgen-20240802.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 22 }, "report": { "R1": { "role": "http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_47ee5328-9d8f-4d8e-b26c-33533f43d710", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "fgen-20240802.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_47ee5328-9d8f-4d8e-b26c-33533f43d710", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "fgen-20240802.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://www.fibrogen.com/20240802/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 12 0000950170-24-092967-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-092967-xbrl.zip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fgen-20240802_htm.xml IDEA: XBRL DOCUMENT 0000921299 2024-08-02 2024-08-02 0000921299 false 8-K 2024-08-02 FIBROGEN, INC. DE 001-36740 77-0357827 409 Illinois Street San Francisco CA 94158 415 978-1200 false false false false Common Stock, $0.01 par value FGEN NASDAQ false